British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Californian companies Gilead Sciences and Genesis Therapeutics have entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets. 10 September 2024
ZipBio, a newly launched start-up based in Seattle, USA, is aiming to set a new standard in the development of biologics and gene therapies by utilizing generative AI technology. 9 September 2024
Otsuka Pharmaceuticals says that its subsidiaries Otsuka Precision Health, Inc. (OPH) and Click Therapeutics (Click) have launched Rejoyn (developed as CT-152). 19 August 2024
CytoReason’s $80 million venture round may not have been the biggest in July, but it is one of a growing number of investor bets on AI powered drug discovery this year. 7 August 2024
A recent survey from IDC highlights that 49% of the pharmaceutical industry believes they have achieved success in implementing artificial intelligence (AI) across the entire pharmacovigilance (PV) value chain. However, over the next two years, the industry expects this number to only marginally shift to just 51%. 17 June 2024
Privately-held company GAIA has had more than a front-row seat to observe the arrival of digital therapeutics and applications of AI in pharma over the past quarter century. 4 June 2024
The use of AI across all industries and sectors has been heralded as driving efficiency and accelerating innovation, with some experts even citing the technology as the biggest disruptor of our lifetime. 21 May 2024
At a cool $1 billion, the venture round secured by AI group Xaira ranks as the second-biggest raise in biotech history. In the drug discovery space, this financing is dwarfed only by Altos Lab’s $3 billion, amassed back in 2021. 14 May 2024
Japanese drugmaker Otsuka Pharmaceutical has become the latest pharma company to show faith in a US firm that develops software to address unmet medical need. 4 January 2019
Does the way artificial intelligence is used in pharma need to be reimagined? Irina Efimenko, chief executive of Russian analytics experts Semantic Hub, and Mike Samsonov, chief medical officer of R-Pharm, consider this question in an Expert View piece. 20 December 2018
Danish diabetes company Novo Nordisk has signed a research collaboration with e-therapeutics, a UK-based company with a computer-based drug discovery platform. 10 December 2018
A new pharma-partnered project has been set up to build a large-scale, federated network of data sources standardized to a common model. 23 November 2018
For the era of personalized therapies to truly arrive, industry observers often express the view that pharma will have to improve its understanding not just of biology and medicines, but also of certain new technologies that are likely to determine companies’ future way of working. 30 October 2018
Russia’s arrival as a major player in the digitalization of healthcare was abundantly clear at a Moscow event held to celebrate and stimulate advances in the sector. 25 October 2018
Denmark’s Novo Nordisk and French pharma major Sanofi lead the pack when it comes to delivering a standout online experience to US patients in the crowded marketplace for type 2 diabetes treatments, a study from DRG Digital Manhattan Research reveals. 23 October 2018
Sumitomo Dainippon Pharma has announced a 700 million yen ($6 million) investment in a company that aims to enhance the functionality of cyborg technologies and the combination of bio-signal processing and robotics. 17 October 2018
In a special report piece, Ed Corbett, principal at specialist pharmaceutical strategy consultants, Novasecta, considers an issue of paramount importance to the future of the industry. 3 October 2018
A cloud-based informatics platform being launched by US pharma giant Merck & Co and Accenture has been launched with the claim that it will improve productivity, efficiency and innovation in the early stages of drug development. 20 September 2018
Supply chain imperatives are evolving from drug production and delivery that are limited in scope towards a versatile supply chain addressing the needs of multiple stakeholders (such as caregivers, patients and insurance companies). The traditional supply chain approach based on materials requirement planning has progressed to its limits. 17 September 2018
Making patients the owners of and beneficiaries from their own data will be key to making blockchain technology deliver for healthcare as a whole, according to the theory behind a network that could convert siloed information into a connected driver of better research and outcomes. 22 August 2018
“The Russian pharma market is like a huge ocean. If you know who lives in the ocean and what sort of currents the ocean has, then it is all simple and understandable.” 10 August 2018
Sanofi Ventures, the investment arm of French pharma major Sanofi has entered into a $17 million deal with New York-based Click Therapeutics. 23 July 2018
For several years, pharma analysts have predicted varying degrees of impact from nascent blockchain technologies. While some suggest wholesale revolution is in the offing, others anticipate more incremental evolution for a conservative industry that is traditionally resistant to change. 23 July 2018
In the latest Expert View piece on artificial intelligence (AI), Christopher Bouton, founder and CEO of Vyasa, a provider of software for the life sciences and healthcare industries, analyzes what the future holds for biopharma in an AI-driven world. 9 May 2018
Akili Interactive, a prescription digital medicine company developing novel treatments for cognitive dysfunction that was founded by London-listed biopharma company PureTech Health, is now $55 million better off following a financing round. 9 May 2018